<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27046001</identifier>
<setSpec>1989-7286</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Contreras-Díaz, M</dc:author>
<dc:author>Medina-Tapia, A</dc:author>
<dc:author>Martínez-Bernal, G</dc:author>
<dc:author>Molina-Socola, F E</dc:author>
<dc:author>Rueda-Rueda, T</dc:author>
<dc:author>Sánchez-Vicente, J L</dc:author>
<dc:author>López-Herrero, F</dc:author>
<dc:description xml:lang="en">CASE REPORT We present the case of a 55-year-old man with a non-small cell lung adenocarcinoma, who presented with choroidal metastasis. The patient showed a decrease in visual acuity. His evaluation revealed unilateral choroidal metastasis secondary to carcinoma of the lung. The patient received afatinib with complete regression of choroidal metastasis after one year follow-up. DISCUSSION Choroidal metastasis may be the initial sign of lung cancer. This case highlights the importance of a thorough systemic evaluation in patients with choroidal tumours. Afatinib was effective against choroidal metastasis of a lung adenocarcinoma with EFGR mutation.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>EFGR mutation</dc:subject>
<dc:subject>Afatinib</dc:subject>
<dc:subject>Mutación EFGR</dc:subject>
<dc:subject>Tumores coroideos</dc:subject>
<dc:subject>Choroidal tumours</dc:subject>
<dc:subject>Adenocarcinoma de pulmón</dc:subject>
<dc:subject>Metástasis coroidea</dc:subject>
<dc:subject>Choroidal metastasis</dc:subject>
<dc:subject>Lung adenocarcinoma</dc:subject>
<dc:date>2016 Nov </dc:date>
<dc:title xml:lang="es">Metástasis coroidea como signo de presentación de un adenocarcinoma de pulmón con respuesta a afatinib.</dc:title>
<dc:title xml:lang="en">Choroidal metastasis as a presenting manifestation of a lung adenocarcinoma with response to afatinib.</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
